close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eaton Vance Ohio Municipal Income Trust (NQ:EVO)

3.560 -0.040 (-1.11%)
Streaming Delayed Price Updated: 3:16 PM EST, Feb 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Eaton Vance Ohio Municipal Income Trust

< Previous 1 2 3 4 5 Next >
News headline image
Evotec Receives US$ 6.6 m Grant for Drug Discovery in Tuberculosis
Via ACCESSWIRE
News headline image
Evotec SE to Announce Preliminary Financial Results for Fiscal Year 2022 on 28 March 2023
Via ACCESSWIRE
News headline image
Evotec Announces Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb
Via ACCESSWIRE
Sernova Corp. (TSX: SVA) Featured in Coverage of the 35th Annual Roth Conference
Via Investor Brand Network
News headline image
Evotec Receives € 150 m Loan from European Investment Bank
Via ACCESSWIRE
News headline image
Evotec and TIAP Expand LAB150 BRIDGE Partnership to Include Amgen
Via ACCESSWIRE
News headline image
Evotec and Related Sciences Expand Integrated Drug Discovery and Development Partnership
Via ACCESSWIRE
News headline image
Evotec SE: Laetitia Rouxel to succeed Enno Spillner as Chief Financial Officer
Via ACCESSWIRE
News headline image
Evotec Announces Agreement with Janssen to Develop Immune-Based Therapies
Via ACCESSWIRE
News headline image
Evotec Achieves Further Progress in Neuroscience Collaboration with Bristol Myers Squibb
Via ACCESSWIRE
News headline image
Evotec SE Reports Results for the First Nine Months 2022 and Provides Corporate Update
Via ACCESSWIRE
News headline image
Evotec SE to Announce Results for the First Nine Months 2022 on 09 November 2022
Via ACCESSWIRE
News headline image
Evotec Completes Acquisition of Central Glass Germany
Via ACCESSWIRE
News headline image
Evotec Presents Paradigm Shift in Biologics at Capital Markets Day
Via ACCESSWIRE
News headline image
Evotec, CDP Venture Capital and Angelini Ventures Launch Translational Partnership 'Extend' with Leading Italian Academic Institutions
Via ACCESSWIRE
News headline image
Evotec Enters Partnership with Hannover Medical School to Create Molecular Patient Database in Autoimmune Diseases
Via ACCESSWIRE
News headline image
Evotec launches PanOmics Data Analysis Platform PanHunter at Bio-IT World
Via ACCESSWIRE
News headline image
TIAP and Evotec Expand LAB150 BRIDGE Partnership to Include Amgen
From Toronto Innovation Acceleration Partners
Via Business Wire
News headline image
Just – Evotec Biologics Awarded Contract from the U.S. Department of Defense Under Accelerated Antibodies Program
Via ACCESSWIRE
News headline image
Evotec Initiates Ground-Breaking for New Biologics Facility J.POD(R) Toulouse, France (EU)
Via ACCESSWIRE
News headline image
Evotec Expands Clinical and Commercial Drug Substance Manufacturing with Acquisition of Central Glass Germany
Via ACCESSWIRE
News headline image
Evotec SE Reports Results for the First Half-year 2022 and Provides Corporate Updates
Via ACCESSWIRE
News headline image
Just - Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303
Via ACCESSWIRE
News headline image
Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303
From Alpine Immune Sciences Inc.
Via Business Wire
News headline image
Evotec SE Reports First Half-year 2022 Results on 11 August 2022
Via ACCESSWIRE
News headline image
Evotec SE Reports Results of Annual General Meeting 2022
HAMBURG, GERMANY / ACCESSWIRE / June 22, 2022 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) today announced that its shareholders approved all proposals the... 
From Evotec SE
Via AccessWire
Topics Artificial Intelligence
News headline image
Evotec Enters a Drug Discovery Collaboration with Janssen
HAMBURG, GERMANY / ACCESSWIRE / June 14, 2022 / Evotec SE (FRA:EVT)(MDAX/TecDAX)(ISIN:DE0005664809)(NASDAQ:EVO) announced today that the Company has entered a drug discovery collaboration with Janssen... 
From Evotec SE
Via AccessWire
News headline image
Evotec Adds Cell Therapy Manufacturing Facility with Acquisition of Rigenerand
CELLS PLATFORM INTEGRATES INNOVATIVE OFF-THE-SHELF IPSC CELL THERAPY DISCOVERY WITH DEVELOPMENT AND MANUFACTURING 
From Evotec AE
Via AccessWire
News headline image
Evotec and Almirall Enter into a Multi-Target Alliance in Medical Dermatology
HAMBURG, GERMANY and BARCELONA, SPAIN / ACCESSWIRE / May 19, 2022 / Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX, ISIN: DE0005664809)(NASDAQ:EVO) and Almirall S.A. (ALM), a global... 
From Evotec AG
Via AccessWire
News headline image
Evotec and Bristol Myers Squibb Extend and Expand Strategic Partnership
HAMBURG, GERMANY / ACCESSWIRE / May 10, 2022 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE 000 566480 9, WKN 566480; NASDAQ:EVO) announces today that the Company has extended and... 
From Evotec AG
Via AccessWire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today